The Imaginary Worlds of ISPOR: Modeled Cost-Effectiveness Claims Published in Value in Health from January 2016 to December 2016
In 2016, a review of modeled cost-effectiveness studies published in Value in Health between January 2015 and December 2015 was presented. The purpose of the review was to consider whether these modeled claims for cost-effectiveness met the standards of normal science: were the claims made credible,...
Main Authors: | Paul C Langley, Taeho Greg Rhee |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2017-05-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/519 |
Similar Items
-
ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds
by: Paul Langley
Published: (2019-11-01) -
Imaginary Worlds: The Status of Modeled Economic Evaluation Claims Published in Value in Health January 2015 to December 2015
by: Paul C Langley, et al.
Published: (2016-07-01) -
Imaginary Worlds: The Status of Simulation Modeling in Claims for Cost-Effectiveness In Diabetes Mellitus
by: Paul C Langley, et al.
Published: (2016-07-01) -
Nothing to Cheer About: Endorsing Imaginary Economic Evaluations and Value Claims with CHEERS 22 [version 1; peer review: 2 approved]
by: Paul Langley
Published: (2022-02-01) -
Imaginary Worlds: The Status of Modeled Quality Adjusted Life Year Claims for New Oral Anticoagulants in Atrial Fibrillation Published Between January 2012 and February 2016
by: Paul C Langley, et al.
Published: (2016-09-01)